Tower Research Capital LLC (TRC) - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 39 filers reported holding ENTRADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,847
+76.2%
1,003
+68.9%
0.00%
Q2 2023$8,993
+47231.6%
594
-54.0%
0.00%
-100.0%
Q1 2023$19
+216.7%
1,292
+189.0%
0.00%
Q4 2022$6
-100.0%
447
-82.2%
0.00%
-100.0%
Q3 2022$40,000
+73.9%
2,508
+0.9%
0.00%
Q1 2022$23,000
-45.2%
2,485
+0.3%
0.00%
-100.0%
Q4 2021$42,0002,4780.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$8,042,56353.88%
MPM ASSET MANAGEMENT LLC 4,425,784$69,927,38737.45%
5AM Venture Management, LLC 4,408,379$69,652,38820.04%
StepStone Group LP 761,277$12,028,1772.68%
TCG Crossover Management, LLC 584,955$9,242,2891.36%
Redmile Group, LLC 1,284,000$20,287,2000.96%
Nan Fung Group Holdings Ltd 49,082$775,4960.63%
Baker Brothers Advisors 4,865,819$76,879,9400.44%
Corton Capital Inc. 10,485$165,6630.08%
CORNERCAP INVESTMENT COUNSEL INC 13,977$220,8370.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders